Technical University of Munich: Obesity Drugs Such as Ozempic and Mounjaro Also Have a Positive Effects on Heart Disease
September 01, 2025
September 01, 2025
MUNICH, Germany, Sept. 1 (TNSjou) -- The Technical University of Munich issued the following news:
* * *
Obesity drugs such as Ozempic and Mounjaro also have a positive effects on heart disease
Reducing heart failure risk by more than 40 percent
Treatment with the anti-obesity medications semaglutide (sold as Ozempic and Wegovy) or tirzepatide (Mounjaro) can reduce health risks for patients with heart failure by more than 40 percent. These find . . .
* * *
Obesity drugs such as Ozempic and Mounjaro also have a positive effects on heart disease
Reducing heart failure risk by more than 40 percent
Treatment with the anti-obesity medications semaglutide (sold as Ozempic and Wegovy) or tirzepatide (Mounjaro) can reduce health risks for patients with heart failure by more than 40 percent. These find . . .